Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Histogen Inc. (0001383701)
Standardized SEC financial data for Histogen Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001383701 · Pharmaceutical Preparations.
Operating margin
-282.4%
Net margin
-294.8%
Revenue growth (YoY)
265.2%
Return on equity
-83.0%
ROIC
-680.3%
Free cash flow
-$9.9M
Debt / equity
0.03×
Current ratio
10.90×
Ratios for fiscal year 2022, standardized from SEC filings.